Early-Stage Prostate Cancer: Why Monitoring Instead of Immediate Treatment Can Be the Best Course
Many men diagnosed with very early, low‑risk prostate cancer may not need immediate treatment. Experts suggest active surveillance—regular PSA tests every six months, annual exams, and periodic imaging and biopsies—with therapy started if tests show progression. This approach can spare patients the side effects of treatment (such as incontinence or impotence) and maintain quality of life, while still allowing timely intervention if needed. Watchful waiting is a separate option for older or less healthy individuals. Screening typically starts at age 50 for average risk (earlier for higher risk), but decisions should be personalized through a discussion with a doctor.
